<< Why was hitting $17 a milestone. >>
Exactly my point. You are very observant! <g>
The question was: If biotechs and Ligand valuations are that simple, why is LGND $11 now, and why was it $17 last year, before they had two NDA's in front of the FDA?
<< Maybe if your sober today >>
You mean: "Maybe, if you're sober today."
Hmmmm!? The question is: Is an insult more, or less, meaningful if it comes from someone, who is somewhat illiterate?
<< ... you can explain why after Lgnd hit $17 that it lost about 40% of its value, in spite of all the good news that has come out? >>
Again, you have badly missed the point of my original note. This doesn't surprise me. <g>
The unfortunate fact is that I am being put into the position of discussing a complex biotech investment with someone of questionable intellect (similar to Fugazi), and who knows very little about Ligand.
Mudrat, to correspond with you on this subject would be a waste of my time, especially when you lead off the question with an insult. |
